<DOC>
	<DOCNO>NCT01768988</DOCNO>
	<brief_summary>This randomize , double blind control , parallel arm trial , aim assess efficacy pregabalin pancreatic cancer induce abdominal pain . The goal study include ( 1 ) assess analgesic effect pregabalin comparison placebo ; assess presence central sensitization potential reversion Pregabalin ; ( 3 ) assessing quality life patient treat pregabalin comparison placebo ; ( 4 ) compare adverse effect patient treat Pregabalin comparison placebo ; ( 5 ) compare anxiety depression patient treat pregabalin comparison placebo .</brief_summary>
	<brief_title>Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain . A Randomized Controlled Double-Blind , Parallel Group Study</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Visceral Pain</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>1 . Patients &gt; 18 year old recently diagnose pancreatic cancer ( &lt; 3 month ) . 2 . Personally sign date informed consent document indicate patient inform pertinent aspect trial . 3 . Patients willing able comply schedule visit , treatment plan , laboratory test trial procedure . 1 . Patients evidence history medical surgical disease importance study judge investigator . 2 . Patients previously diagnose moderate severe renal impairment . Those Clearance Creatinine ( CLcr ) &lt; 60mL/min exclude . 3 . Patients treat anticonvulsant previous 4 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>